The present disclosure provides compounds and methods for inhibiting the interaction of menin with its upstream or downstream signaling molecules including but not limited to MLL1, MLL2 and MLL-fusion oncoproteins. Compounds of the disclosure may be used in methods for the treatment of a wide variety of cancers and other diseases associated with one or more of MLL1, MLL2, MLL fusion proteins, and menin.
本公开提供了抑制menin与其上游或下游信号分子相互作用的化合物和方法,包括但不限于MLL1、ML
L2和MLL融合致癌蛋白。本公开的化合物可用于治疗与MLL1、ML
L2、MLL融合蛋白和menin之一或多个相关的各种癌症和其他疾病的方法。